Suicide prevention inpatient group treatment—A treatment development and feasibility study
Suicide and Life-Threatening Behavior · 2025
DOI: 10.1111/sltb.13154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Suicide and Life-Threatening Behavior, 2025. Verfasst von Yael Holoshitz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Vagelos College of Physicians & Surgeons, New York, New York, USA. Hauptthemen laut MEDLINE: Suicide Prevention, Inpatients, Psychotherapy, Group. Die Arbeit nennt 52 Literaturangaben. Gefördert von: New York State Office of Mental Health.
Abstract (Originalsprache)
Background
One mainstay of psychiatric treatment for suicidal crises is inpatient psychiatric hospitalization. Despite the need to secure immediate safety and stabilization, inpatient treatment for acutely suicidal patients remains diagnosis‐specific, which may fail to directly target and adequately manage suicidal behavior as a symptom and reason for admission or treatment. The post‐discharge period is a high‐risk period for repeat suicide attempts or death by suicide, but overburdened workforce and high patient turnover make it difficult to provide suicide‐specific treatment.
Methods
In response to this need, we developed the Suicide Prevention Inpatient Group Treatment (SPIGT), a four‐module, group‐based intervention, which provides evidence‐supported concrete tools and psychoeducation to directly address suicidality. To assess feasibility and acceptability of implementation, the SPIGT was piloted on an inpatient psychiatric unit starting in 2016. Group participants were given optional, anonymous surveys after each module. Unit clinicians also completed optional, anonymous surveys to assess their attitudes towards the intervention.
Results
Results indicate that participants responded very favorably to each module, and that unit clinicians felt that the implementation of this intervention was feasible and acceptable.
Conclusion
The SPIGT shows promise as a scalable suicide‐specific, brief intervention, which addresses an unmet and critical need in suicide prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Columbia University Vagelos College of Physicians & Surgeons, New York, New York, USA.
- New York State Psychiatric Institute, New York, New York, USA.
ORCID-Profile: Yael Holoshitz, Christa D Labouliere
Förderung
- New York State Office of Mental Health
Zitieren
APA
Holoshitz, Y., Mehta, H., Itzhaky, L., Cid, A., DeSilva, R., Gilbert, S., Kaufmann, C., Labouliere, C. D., Brodsky, B., & Stanley, B. (2025). Suicide prevention inpatient group treatment—A treatment development and feasibility study. Suicide and Life-Threatening Behavior. https://doi.org/10.1111/sltb.13154
Vancouver
Holoshitz Y, Mehta H, Itzhaky L, Cid A, DeSilva R, Gilbert S, et al. Suicide prevention inpatient group treatment—A treatment development and feasibility study. Suicide and Life-Threatening Behavior. 2025. doi:10.1111/sltb.13154
BibTeX
@article{Holoshitz2025,
author = {Holoshitz, Yael and Mehta, Haitisha and Itzhaky, Liat and Cid, Ariana and DeSilva, Ravi and Gilbert, Sarah and Kaufmann, Cassie and Labouliere, Christa D and Brodsky, Beth and Stanley, Barbara},
title = {Suicide prevention inpatient group treatment—A treatment development and feasibility study},
journal = {Suicide and Life-Threatening Behavior},
year = {2025},
doi = {10.1111/sltb.13154}
}
EUVIMED